Profile
Nutricia North America is part of Royal Numico N.V., a global leader in infant and clinical nutrition. The clinical division of the company specializes in the manufacture, marketing and distribution of medical foods and infant formulas for the dietary management of rare genetic, metabolic, allergic, gastrointestinal and neurological disorders.

Nutricia North America, initially known as SHS North America, was established in the United States in 1983. The company is located on the Human Genome Sciences Campus just outside Washington, D.C. The Nutricia team is known for setting the standard in the delivery of quality products and educational materials for consumers and healthcare professionals.

The Nutricia product line consists of a wide variety of FDA and Health Canada approved products used in the management of inherited metabolic diseases, severe allergic and gastrointestinal disorders as well as other conditions requiring nutritional therapy.

Nutricia was the first to create amino acid-based, hypoallergenic formulas (the Neocate product line) for the dietary management of cow milk protein allergy. The company has played a prominent role in educating the medical community through clinical trials and symposia on cow milk allergy and its associated enteropathies. Nutricia has recently diversified its product range by offering products specifically designed for intractable epilepsy—available under the brand name KetoCal—and innovative options for patients with phenylketonuria. For a full listing and detailed information on Nutricia North America’s products, please visit www.nutricia-na.com.

While the demand for clinical nutrition as a medical therapy continues to expand, Nutricia works in close partnership with leading physicians and dietitians to identify patient needs. Part of Royal Numico, Nutricia's reputation continues to grow as an innovator in research and development, thereby meeting the demands of today's patients and the medical community.